10-QPeriod: Q1 FY2011

HCA Healthcare, Inc. Quarterly Report for Q1 Ended Mar 31, 2011

Filed May 11, 2011For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed its quarterly report on May 10, 2011, for the period ending March 30, 2011. A significant event during this period was the company's initial public offering (IPO) on March 15, 2011, where it raised approximately $2.5 billion in net proceeds. These proceeds were initially used to temporarily repay outstanding indebtedness under revolving credit facilities. Investors should note that HCA operates in a highly regulated and litigious healthcare industry. The company is subject to various government investigations, including a review by the Department of Justice regarding billing for implantable cardio-defibrillators (ICDs) at 87 HCA hospitals. Furthermore, changes in government healthcare programs, such as Medicare and Medicaid, represent a significant risk factor, with approximately 41% of HCA's revenues derived from these programs in 2010. Proposed changes to Medicare reimbursement rates and state budget pressures affecting Medicaid reimbursements could adversely impact future revenues.

Financial Highlights

44 data points
Beta

Revenue

$7.41B

Net Income

$240.00M

3.2% Net Margin

EPS (Diluted)

$0.52

Total Assets

$23.81B

Cash & Equivalents

$553.00M

Free Cash Flow

$589.00M

Financial Statements
Beta
Revenue$7.41B
Interest Expense$533.00M
Net Income$240.00M
EPS (Basic)$0.54
EPS (Diluted)$0.52
Shares Outstanding (Basic)444.20M
Shares Outstanding (Diluted)461.97M

Key Highlights

  • 1HCA Healthcare completed its initial public offering (IPO) on March 15, 2011, raising approximately $2.5 billion in net proceeds.
  • 2The company used a significant portion of the IPO proceeds to temporarily repay outstanding debt.
  • 3HCA is subject to ongoing government investigations, including a DOJ review of ICD billing practices across 87 hospitals.
  • 4Approximately 41% of HCA's 2010 revenue was derived from Medicare and Medicaid programs, making the company vulnerable to changes in these government reimbursements.
  • 5Proposed changes to Medicare reimbursement rates and state budget constraints impacting Medicaid could adversely affect future financial results.
  • 6The company's disclosure controls and procedures were evaluated and found to be effective, with no material changes to internal controls over financial reporting during the period.
  • 7Bylaws were amended in connection with the IPO to implement new procedures for stockholder nominations and business proposals at meetings.

Frequently Asked Questions

The most significant financial event was the company's initial public offering (IPO) on March 15, 2011, which generated approximately $2.5 billion in net proceeds. These funds were primarily used to temporarily pay down outstanding debt.

HCA faces significant risks related to government healthcare programs, which accounted for about 41% of its revenue in 2010. Changes in Medicare and Medicaid reimbursement rates, as well as ongoing government investigations (such as the DOJ review of ICD billing), pose material risks to the company's financial condition and results of operations. The company also operates in a highly litigious environment.

Yes, HCA is subject to various government investigations and litigious matters. Notably, the Department of Justice is reviewing ICD billing practices at 87 HCA hospitals. The company also mentions ongoing legal proceedings, such as a lawsuit in New Hampshire related to hospital transactions, and acknowledges the potential for adverse effects from the resolution of such matters.

Changes in Medicare and Medicaid programs represent a substantial risk. Reductions in reimbursement rates due to legislative and regulatory changes (like the Health Reform Law and MS-DRG system adjustments) could decrease revenues. Additionally, state budget pressures may lead to reduced Medicaid reimbursements, as exemplified by a potential reduction in Florida.